Security key
71715X104
PHARMACYTE BIOTECH INC COM NEW - Stock (PMCB)
CUSIP: 71715X104
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Stock
- Total 13F shares
- 31
- Total 13F value
- $73
- Share change
- 0
- SEC-reported price per share
- $2.37
- Number of holders
- 3
Report period
Q1 2024
Institutions
3
Top holders
3
PMCB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
PharmaCyte Biotech, Inc. SEC filings
PharmaCyte Biotech, Inc. company facts
PharmaCyte Biotech, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 71715X104
Recent filing periods:
Ownership snapshot
Top reported holders of PMCB - PHARMACYTE BIOTECH INC COM NEW - Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
K2 PRINCIPAL FUND, L.P.
Disclosed value leader
K2 PRINCIPAL FUND, L.P.
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $654,918
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
K2 PRINCIPAL FUND, L.P. has the largest disclosed position value at $654.9K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens K2 PRINCIPAL FUND, L.P.'s linked filing trail.
Disclosed position value
Top 5
K2 PRINCIPAL FUND, L.P.
$654.9K
GEODE CAPITAL MANAGEMENT, LLC
$465.8K
VANGUARD GROUP INC
$370.1K
EQUITEC PROPRIETARY MARKETS, LLC
$178.7K
SABBY MANAGEMENT, LLC
$177.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. |
13F
Company
|
—
denominator unverified
|
$654,918
304,613 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$465,801
215,637 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$370,084
171,335 shares
|
— | 31 Dec 2023 |
| EQUITEC PROPRIETARY MARKETS, LLC |
13F
Company
|
—
denominator unverified
|
$178,690
82,727 shares
|
— | 31 Dec 2023 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$177,926
82,373 shares
|
— | 31 Dec 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$82,000
38,100 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
31
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q2 2026 Across Filers
Q2 2026 holders
3
Q1 2024 holders
3
Holder diff
0
| Investor | Q2 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend